A carregar...
Dopamine D(2) receptor and β-arrestin 2 mediate Amyloid-β elevation induced by anti-parkinson’s disease drugs, levodopa and piribedil, in neuronal cells
Although levodopa is the first-line medication for the treatment of Parkinson’s disease (PD) showing unsurpassable efficiency, its chronic use causes dyskinesia. Accordingly, dopamine agonists are increasingly employed as monotherapy or in combination with levodopa to reduce the risk of motor compli...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5333886/ https://ncbi.nlm.nih.gov/pubmed/28253352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0173240 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|